1. Elyakov Pacibic Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, Vladivostok, Russia; Far Eastern Federal University, Vladivostok, Russia 2. Elyakov Pacibic Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, Vladivostok, Russia
The review considers recent experimental studies of biological activity and mechanisms of therapeutic action of rosmarinic acid, luteolin and its sulfated derivatives in diseases associated with disorders of carbohydrate and lipid metabolism. Particular attention is focused on the results of studies showing a high therapeutic potential of these phenolic compounds in their prophylactic and therapeutic use at experimental modeling of type 2 diabetes and hyperlipidemia. Based on the analysis of our results and the literature data putative mechanisms of therapeutic action of rosmarinic acid, luteolin and its sulfated derivatives have been proposed.
Download PDF:
Keywords: flavonoids, luteolin, rosmarinic acid, type 2 diabetes, hyperlipidemia, atherosclerosis
Citation:
Popov A.M., Krivoshapko O.N., Klimovich A.A., Artyukov A.A. (2016) Biological activity and mechanisms of therapeutic action of rosmarinic acid, luteolin and its sulphated derivatives. Biomeditsinskaya Khimiya, 62(1), 22-30.
Popov A.M. et al. Biological activity and mechanisms of therapeutic action of rosmarinic acid, luteolin and its sulphated derivatives // Biomeditsinskaya Khimiya. - 2016. - V. 62. -N 1. - P. 22-30.
Popov A.M. et al., "Biological activity and mechanisms of therapeutic action of rosmarinic acid, luteolin and its sulphated derivatives." Biomeditsinskaya Khimiya 62.1 (2016): 22-30.
Popov, A. M., Krivoshapko, O. N., Klimovich, A. A., Artyukov, A. A. (2016). Biological activity and mechanisms of therapeutic action of rosmarinic acid, luteolin and its sulphated derivatives. Biomeditsinskaya Khimiya, 62(1), 22-30.
Xagorari A., Papapetropoulos A., Mauromatis A., Economou M., Fotsis T., Roussos C. (2001) J. Pharmacol. Exp. Ther., 296, 181-187. Scholar google search
Park H.S., Kim S.H., Kim Y.S., Ryu S.Y., Hwang J.T., Yang H.J., Kim G.H., Kwon D.Y., Kim M.S. (2009) Biofactors, 35, 373-379. CrossRef Scholar google search
Puhl A.C., Bernardes A., Silveira R.L., Yuan J., Campos J.L., Saidemberg D.M., Palma M.S., Cvoro A., Ayers S.D., Webb P., Reinach P.S., Skaf M.S., Polikarpov I. (2012) Mol. Pharmacol., 81(6), 788-799. CrossRef Scholar google search
Lopez-Lazaro M. (2009) Mini-Reviews in Med. Chem., 9(1), 31-59. Scholar google search
Robak J., Shridi F., Wolbis M., Krolikowska M. (1988) Pol. J. Pharmacol. Pharm., 40, 451-458. CrossRef Scholar google search
Paredes-Gonzalez X., Fuentes F., Jeffery S., Saw C.L., Shu L., Su Z.Y., Kong A.N. (2015) Biopharm. Drug Dispos., doi: 10.1002/bdd.1956. CrossRef Scholar google search
Hoshino J., Park E.J., Kondratyuk T.P., Marler L., Pezzuto J.M., van Breemen R.B., Mo S., Li Y., Cushman M. (2010) J. Med. Chem., 53, 5033-5043. CrossRef Scholar google search
